Skip to main content
. 2016 Aug 23;12(4):2265–2274. doi: 10.3892/etm.2016.3610

Figure 1.

Figure 1.

Single-factor statistical analysis of first therapeutic-target-achieving time. Respective associations between the first standard time and (A) initial dose, (B) body mass index (BMI), (C) heart failure incidence, (D) liver function and (E) levofloxacin administration. The χ2 test was used for statistical analysis.